利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.052 秒)

    Apparatus for multiple antennas in wireless communication system
    1.
    发明授权
    Apparatus for multiple antennas in wireless communication system 有权
    无线通信系统中多个天线的装置

    公开(公告)号：US08654032B2

    公开(公告)日：2014-02-18

    申请号：US13008149

    申请日：2011-01-18

    申请人： Byung-Tae Yoon ,  Jong-Wook Zeong ,  Jae-Hoon Jo ,  Mi-Hyun Son ,  Se-Hyun Park ,  Hee-Jun Lee

    发明人： Byung-Tae Yoon ,  Jong-Wook Zeong ,  Jae-Hoon Jo ,  Mi-Hyun Son ,  Se-Hyun Park ,  Hee-Jun Lee

    IPC分类号： H01Q21/10 ,  H01Q1/24

    CPC分类号： H01Q1/521 ,  H01Q1/525 ,  H01Q21/28

    摘要： An apparatus for multiple antennas having a low coupling coefficient in a wide frequency bandwidth in a wireless communication system is provided. To obtain the low coupling coefficient in the wide frequency bandwidth by minimizing interference between antennas which are close to each other, without an additional device, in the wireless communication system, the apparatus includes a transceiver and a line for decreasing a coupling coefficient. The transmitter includes a first antenna and a second antenna for transmitting and receiving signals over a radio channel and the line is indirectly connected the first antenna and the second antenna using a physically disconnected line.

    摘要翻译： 提供了一种在无线通信系统中在宽频带宽中具有低耦合系数的多个天线的装置。 为了通过最小化彼此接近的天线之间的干扰来获得宽频带宽的低耦合系数，在无线通信系统中，该装置包括收发机和用于减小耦合系数的线路。 发射机包括第一天线和第二天线，用于通过无线电信道发送和接收信号，并且线路使用物理断开的线路间接连接第一天线和第二天线。

    Method for fabricating antenna device of mobile communication terminal
    3.
    发明授权
    Method for fabricating antenna device of mobile communication terminal 有权
    移动通信终端天线装置的制造方法

    公开(公告)号：US08353097B2

    公开(公告)日：2013-01-15

    申请号：US12841389

    申请日：2010-07-22

    申请人： Joon-Ho Byun ,  Seong-Tae Jeong ,  Bum-Jin Cho ,  Soon-Ho Hwang ,  Yong-Soo Kwak ,  Austin Kim ,  Jae-Hoon Jo ,  Jae-Hyung Kim ,  A-Hyun Sin

    发明人： Joon-Ho Byun ,  Seong-Tae Jeong ,  Bum-Jin Cho ,  Soon-Ho Hwang ,  Yong-Soo Kwak ,  Austin Kim ,  Jae-Hoon Jo ,  Jae-Hyung Kim ,  A-Hyun Sin

    IPC分类号： H01P11/00

    CPC分类号： H01Q1/38 ,  H01Q1/243 ,  Y10T29/49002 ,  Y10T29/49016

    摘要： A method for fabricating an antenna device of a mobile communication terminal, the method including selecting radiation patterns according to a usable frequency band, selecting and fabricating magneto dielectric modules for adjusting resonance frequencies of the selected radiation patterns, selecting and fabricating dielectric modules for adjusting resonance frequency of the selected radiation patterns, selecting and fabricating a radiation pattern having a number of resonance frequencies required for the terminal from among the radiation patterns selected in the pattern selection step, and selecting at least one of the magneto dielectric modules and the dielectric modules and installing it in the radiation pattern to tune a resonance frequency of the radiation pattern to the resonance frequency required for the terminal.

    摘要翻译： 一种用于制造移动通信终端的天线装置的方法，所述方法包括根据可用频带选择辐射图案，选择和制造用于调节所选择的辐射图案的共振频率的磁介质模块，选择和制造用于调节共振的电介质模块 所选择的辐射图案的频率，从在图案选择步骤中选择的辐射图案中选择并制造具有终端所需的多个谐振频率的辐射图案，以及选择磁介质模块和电介质模块中的至少一个，以及 将其安装在辐射图中以将辐射图的谐振频率调谐到终端所需的共振频率。

    Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant
    4.
    发明授权
    Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant 有权
    经鼻抗惊厥药物组合物包含难溶性抗惊厥药

    公开(公告)号：US08592406B2

    公开(公告)日：2013-11-26

    申请号：US12940563

    申请日：2010-11-05

    申请人： Myoung-Ki Baek ,  Jae-Hoon Jo ,  Hye-Jin Chang

    发明人： Myoung-Ki Baek ,  Jae-Hoon Jo ,  Hye-Jin Chang

    IPC分类号： A61K9/08

    CPC分类号： A61K31/5513 ,  A61K9/0043 ,  A61K47/26 ,  A61K47/44 ,  Y02A50/465

    摘要： There is provided a transnasal anticonvulsive pharmaceutical composition including a poorly soluble anticonvulsant. The anticonvulsive pharmaceutical composition comprising a poorly soluble anticonvulsant as an active component, which is transnasally spray-administered, comprises diethylene glycol monoethyl ether and fatty acid ester, wherein the fatty acid ester is selected from the group consisting of caprylocaproyl polyoxylglyceride, isopropyl palmitate, oleoyl polyoxylglyceride, sorbitan monolaurate 20, methyl laurate, ethyl laurate, and polysorbate 20. Also, the anticonvulsive pharmaceutical composition comprising a poorly soluble anticonvulsant as an active component, which is transnasally spray-administered, comprises diethylene glycol monoethyl ether, fatty acid ester, methylpyrrolidone, water and alcohol. Therefore, the transnasal anticonvulsive pharmaceutical composition may be useful to highly enhance the bioavailability of the poorly soluble anticonvulsant. Also, the transnasal anticonvulsive pharmaceutical composition may be useful to allow the poorly soluble anticonvulsant to show the improved viscosity and/or enhanced solubility in order to effectively deliver the poorly soluble anticonvulsant at a therapeutic dose.

    摘要翻译： 提供了包含难溶性抗惊厥药的经鼻抗惊厥药物组合物。 包含作为经鼻喷雾给药的作为活性成分的难溶性抗惊厥药的抗惊厥药物组合物包含二甘醇单乙醚和脂肪酸酯，其中所述脂肪酸酯选自辛酰己酰基聚氧乙烯甘油酯，棕榈酸异丙酯，油酰基 聚氧乙烯甘油酯，脱水山梨糖醇单月桂酸酯20，月桂酸甲酯，月桂酸乙酯和聚山梨酸酯20.此外，通过经鼻喷雾给药的包含作为活性成分的难溶性抗惊厥药的抗惊厥药物组合物包括二甘醇单乙醚，脂肪酸酯，甲基吡咯烷酮 ，水和酒精。 因此，经鼻抗惊厥药物组合物可用于高度增强难溶性抗惊厥药的生物利用度。 此外，经鼻抗惊厥药物组合物可用于使难溶性抗惊厥药显示出改善的粘度和/或增加的溶解性，以有效递送治疗剂量下的难溶性抗惊厥药。

    Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant
    6.
    发明申请
    Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant 有权
    包括不良溶解抗惊厥药的经鼻抗惊厥药物组合物

    公开(公告)号：US20110172211A1

    公开(公告)日：2011-07-14

    申请号：US12940563

    申请日：2010-11-05

    申请人： Myoung-Ki Baek ,  Jae-Hoon Jo ,  Hye-Jin Chang

    发明人： Myoung-Ki Baek ,  Jae-Hoon Jo ,  Hye-Jin Chang

    IPC分类号： A61K31/5513 ,  A61P25/08

    CPC分类号： A61K31/5513 ,  A61K9/0043 ,  A61K47/26 ,  A61K47/44 ,  Y02A50/465

    摘要： There is provided a transnasal anticonvulsive pharmaceutical composition including a poorly soluble anti-convulsant. The anticonvulsive pharmaceutical composition comprising a poorly soluble anticonvulsant as an active component, which is transnasally spray-administered, comprises diethylene glycol monoethyl ether and fatty acid ester, wherein the fatty acid ester is selected from the group consisting of caprylocaproyl polyoxylglyceride, isopropyl palmitate, oleoyl polyoxylglyceride, sorbitan monolaurate 20, methyl laurate, ethyl laurate, and polysorbate 20. Also, the anticonvulsive pharmaceutical composition comprising a poorly soluble anticonvulsant as an active component, which is transnasally spray-administered, comprises diethylene glycol monoethyl ether, fatty acid ester, methylpyrrolidone, water and alcohol. Therefore, the transnasal anticonvulsive pharmaceutical composition may be useful to highly enhance the bioavailability of the poorly soluble anticonvulsant. Also, the transnasal anticonvulsive pharmaceutical composition may be useful to allow the poorly soluble anticonvulsant to show the improved viscosity and/or enhanced solubility in order to effectively deliver the poorly soluble anticonvulsant at a therapeutic dose.

    摘要翻译： 提供了包含难溶性抗惊厥药的经鼻抗惊厥药物组合物。 包含作为经鼻喷雾给药的作为活性成分的难溶性抗惊厥药的抗惊厥药物组合物包含二甘醇单乙醚和脂肪酸酯，其中所述脂肪酸酯选自辛酰己酰基聚氧乙烯甘油酯，棕榈酸异丙酯，油酰基 聚氧乙烯甘油酯，脱水山梨糖醇单月桂酸酯20，月桂酸甲酯，月桂酸乙酯和聚山梨酸酯20.此外，通过经鼻喷雾给药的包含作为活性成分的难溶性抗惊厥药的抗惊厥药物组合物包括二甘醇单乙醚，脂肪酸酯，甲基吡咯烷酮 ，水和酒精。 因此，经鼻抗惊厥药物组合物可用于高度增强难溶性抗惊厥药的生物利用度。 此外，经鼻抗惊厥药物组合物可用于使难溶性抗惊厥药显示出改善的粘度和/或增加的溶解性，以有效递送治疗剂量下的难溶性抗惊厥药。

    Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant
    8.
    发明申请
    Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant 有权
    包括不良溶解抗惊厥药的经鼻抗惊厥药物组合物

    公开(公告)号：US20120190670A9

    公开(公告)日：2012-07-26

    申请号：US12940563

    申请日：2010-11-05

    申请人： Myoung-Ki Baek ,  Jae-Hoon Jo ,  Hye-Jin Chang

    发明人： Myoung-Ki Baek ,  Jae-Hoon Jo ,  Hye-Jin Chang

    IPC分类号： A61K31/5513 ,  A61P25/08

    CPC分类号： A61K31/5513 ,  A61K9/0043 ,  A61K47/26 ,  A61K47/44 ,  Y02A50/465

    摘要： There is provided a transnasal anticonvulsive pharmaceutical composition including a poorly soluble anti-convulsant. The anticonvulsive pharmaceutical composition comprising a poorly soluble anticonvulsant as an active component, which is transnasally spray-administered, comprises diethylene glycol monoethyl ether and fatty acid ester, wherein the fatty acid ester is selected from the group consisting of caprylocaproyl polyoxylglyceride, isopropyl palmitate, oleoyl polyoxylglyceride, sorbitan monolaurate 20, methyl laurate, ethyl laurate, and polysorbate 20. Also, the anticonvulsive pharmaceutical composition comprising a poorly soluble anticonvulsant as an active component, which is transnasally spray-administered, comprises diethylene glycol monoethyl ether, fatty acid ester, methylpyrrolidone, water and alcohol. Therefore, the transnasal anticonvulsive pharmaceutical composition may be useful to highly enhance the bioavailability of the poorly soluble anticonvulsant. Also, the transnasal anticonvulsive pharmaceutical composition may be useful to allow the poorly soluble anticonvulsant to show the improved viscosity and/or enhanced solubility in order to effectively deliver the poorly soluble anticonvulsant at a therapeutic dose.

    摘要翻译： 提供了包含难溶性抗惊厥药的经鼻抗惊厥药物组合物。 包含作为经鼻喷雾给药的作为活性成分的难溶性抗惊厥药的抗惊厥药物组合物包含二甘醇单乙醚和脂肪酸酯，其中所述脂肪酸酯选自辛酰己酰基聚氧乙烯甘油酯，棕榈酸异丙酯，油酰基 聚氧乙烯甘油酯，脱水山梨糖醇单月桂酸酯20，月桂酸甲酯，月桂酸乙酯和聚山梨酸酯20.此外，通过经鼻喷雾给药的包含作为活性成分的难溶性抗惊厥药的抗惊厥药物组合物包括二甘醇单乙醚，脂肪酸酯，甲基吡咯烷酮 ，水和酒精。 因此，经鼻抗惊厥药物组合物可用于高度增强难溶性抗惊厥药的生物利用度。 此外，经鼻抗惊厥药物组合物可用于使难溶性抗惊厥药显示出改善的粘度和/或增加的溶解性，以有效递送治疗剂量下的难溶性抗惊厥药。